BONS.TA
Price:
$25.2
Market Cap:
$294.32M
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company's products include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS, as well as other life-threatening acute inflammatory diseases. Its products in pipeline comprise bone augmentation in osteoporosis patients; novel nano-materials for drug delivery; vascularized bone grafts; and soft tissue grafts. The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.
Industry
Biotechnology
IPO Date
2002-08-12
Stock Exchange
TLV
Ticker
BONS.TA
According to Bonus BioGroup Ltd.’s latest financial reports and current stock price. The company's current ROE is -209.58%. This represents a change of 241.19% compared to the average of -61.43% of the last 4 quarters.
The mean historical ROE of Bonus BioGroup Ltd. over the last ten years is 191.06%. The current -209.58% ROE has changed -209.69% with respect to the historical average. Over the past ten years (40 quarters), BONS.TA's ROE was at its highest in in the March 2015 quarter at 563.83%. The ROE was at its lowest in in the June 2015 quarter at -3596.34%.
Average
191.06%
Median
81.04%
Minimum
-106.69%
Maximum
968.97%
Discovering the peaks and valleys of Bonus BioGroup Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 86.40%
Maximum Annual ROE = 968.97%
Minimum Annual Increase = -152.22%
Minimum Annual ROE = -106.69%
Year | ROE | Change |
---|---|---|
2024 | 0% | -100.00% |
2023 | -97.35% | 41.84% |
2022 | -68.64% | -35.67% |
2021 | -106.69% | 48.66% |
2020 | -71.77% | -144.28% |
2019 | 162.09% | -72.51% |
2018 | 589.71% | 86.40% |
2017 | 316.37% | 45.17% |
2016 | 217.93% | -77.51% |
2015 | 968.97% | -152.22% |
The current ROE of Bonus BioGroup Ltd. (BONS.TA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-55.33%
5-year avg
-68.89%
10-year avg
191.06%
Bonus BioGroup Ltd.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bonus BioGroup Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bonus BioGroup Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bonus BioGroup Ltd.'s ROE?
How is the ROE calculated for Bonus BioGroup Ltd. (BONS.TA)?
What is the highest ROE for Bonus BioGroup Ltd. (BONS.TA)?
What is the 3-year average ROE for Bonus BioGroup Ltd. (BONS.TA)?
What is the 5-year average ROE for Bonus BioGroup Ltd. (BONS.TA)?
How does the current ROE for Bonus BioGroup Ltd. (BONS.TA) compare to its historical average?